The effects of wnt inhibitors on the chondrogenesis of human mesenchymal stem cells

Tissue Engineering - Part A

Volumn 16, Issue 7, 2010, Pages 2405-2413

  Im, Gun Il ^a   Quan, Zhejiu ^a  

^a Dongguk University Ilsan Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CARTILAGE; COLLAGEN; FLOWCHARTING; GENE EXPRESSION; ORE PELLETS; PELLETIZING; STEM CELLS; TISSUE ENGINEERING;

CARTILAGE TISSUE ENGINEERING; CHONDROGENESIS; CHONDROGENIC; GLYCOSAMINOGLYCANS; HUMAN MESENCHYMAL STEM CELLS; HUMAN MESENCHYMAL STEM CELLS (HMSCS); IN-VITRO; PROTEIN EXPRESSIONS; TRANSFORMING GROWTH FACTORS; TYPE II COLLAGENS; WNT PATHWAY;

CELL CULTURE;

BETA CATENIN; COL2A1 PROTEIN, HUMAN; COLLAGEN TYPE 2; DKK1 PROTEIN, HUMAN; DNA; FRZB PROTEIN; GLYCOPROTEIN; GLYCOSAMINOGLYCAN; SIGNAL PEPTIDE; TRANSCRIPTION FACTOR SOX9; TRANSFORMING GROWTH FACTOR BETA3; WNT PROTEIN;

ADULT; ARTICLE; BIOSYNTHESIS; CELL SURVIVAL; CHONDROGENESIS; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MESENCHYMAL STEM CELL; METABOLISM; MIDDLE AGED; TIME;

ADULT; BETA CATENIN; CELL SURVIVAL; CHONDROGENESIS; COLLAGEN TYPE II; DNA; GENE EXPRESSION REGULATION; GLYCOPROTEINS; GLYCOSAMINOGLYCANS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MESENCHYMAL STEM CELLS; MIDDLE AGED; SOX9 TRANSCRIPTION FACTOR; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA3; WNT PROTEINS;

EID: 77954483370     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2009.0359     Document Type: Article

References (18)

1. Pelttari, K., Winter, A., Steck, E., Goetzke, K., Henning, T., Ochs, B.G., Aigner, T., and Richter, W. Premature induction of hypertrophy during in vitro chondrogenesis of human mesenchymal stem cells correlates with calcification and vascular invasion after ectopic transplantation in SCID mice. Arthritis Rheum 54, 3254, 2006.
2. De Bari, C., Dell'Accio, F., Tylzanowski, P., and Luyten, F.P. Multipotent mesenchymal stem cells from adult human sy-novial membrane. Arthritis Rheum 44, 1928, 2001.
3. Johnstone, B., Hering, T.M., Caplan, A.I., Goldberg, V.M., and Yoo, J.U. In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp Cell Res 238, 265, 1998.
4. Barry, F., Boynton, R.E., Liu, B., and Murphy, J.M. Chon-drogenic differentiation of mesenchymal stem cells from bone marrow: differentiation- dependent gene expression of matrix components. Exp Cell Res 268, 189, 2001.
5. Sekiya, I., Larson, B.L., Vuoristo, J.T., Reger, R.L., and Prockop, D.J. Comparison of effect of BMP-2,-4, and-6 on in vitro cartilage formation of human adult stem cells from bone marrow stroma. Cell Tissue Res 320, 269, 2005.
6. Worster, A.A., Brower-Toland, B.D., Fortier, L.A., Bent, S.J., Williams, J., and Nixon, A.J. Chondrocytic differentiation of mesenchymal stem cells sequentially exposed to transforming growth factor-beta1 in monolayer and insulin-like growth factor-I in a three-dimensional matrix. J Orthop Res 19, 738, 2001.
7. Kim, Y.J., Kim, H.J., and Im, G.I. PTHrP promotes chon-drogenesis and suppresses hypertrophy from both bone marrow-derived and adipose tissue-derived MSCs. Biochem Biophys Res Commun 373, 104, 2008.
8. Oh, C.D., Chang, S.H., Yoon, Y.M., Lee, S.J., Lee, Y.S., Kang, S.S., and Chun, J.S. Opposing role of mitogen-activated protein kinase subtypes, erk-1=2 and p38, in the regulation of chondrogenesis of mesenchymes. J Biol Chem 275, 5613, 2000. 9.
9. Day, T.F., Guo, X., Garrett-Beal, L., and Yang, Y. Wnt= beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Dev Cell 8, 739, 2005.
10. Hill, T.P., Später, D., Taketo, M.M., Birchmeier, W., and Hartmann, C. Canonical Wnt=beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes. Dev Cell 8, 727, 2005.
11. Akiyama, H., Lyons, J.P., Mori-Akiyama, Y., Yang, X., Zhang, R., Zhang, Z., Deng, J.M., Taketo, M.M., Nakamura, T., Behringer, R.R., McCrea, P.D., and de Crombrugghe, B. Interactions between Sox9 and beta-catenin control chon-drocyte differentiation. Genes Dev 18, 1072, 2004.
12. Dong, Y.F., Soung, D.Y., Schwarz, E.M., O'Keefe, R.J., and Drissi, H. Wnt induction of chondrocyte hypertrophy through the Runx2 transcription factor. J Cell Physiol 208, 77, 2006.
13. Gaur, T., Lengner, C.J., Hovhannisyan, H., Bhat, R.A., Bo-dine, P.V., Komm, B.S., Javed, A., van Wijnen, A.J., Stein, J.L., Stein, G.S., and Lian, J.B. Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression. J Biol Chem 280, 33132, 2005.
14. Johnson, M.L., and Kamel, M.A. The Wnt signaling pathway and bone metabolism. Curr Opin Rheumatol 19, 376, 2007.
15. Bodine, P.V., and Komm, B.S. Wnt signaling and osteo-blastogenesis. Rev Endocr Metab Disord 7, 33, 2006.
16. Gaur, T., Rich, L., Lengner, C.J., Hussain, S., Trevant, B., Ayers, D., Stein, J.L., Bodine, P.V., Komm, B.S., Stein, G.S., and Lian, J.B. Secreted frizzled related protein 1 regulates Wnt signaling for BMP2 induced chondrocyte differentiation. J Cell Physiol 208, 87, 2006.
17. Kim, H.J., and Im, G.I. Combination of transforming growth factor-beta(2) and bone morphogenetic protein 7 enhances chondrogenesis from adipose tissue-derived mes-enchymal stem cells. Tissue Eng Part A 15, 1543, 2009.
18. Kim, H.J, and Im, G.I. Chondrogenic differentiation of adipose tissue-derived mesenchymal stem cells: greater doses of growth factor are necessary. J Orthop Res 27, 612, 2009.